Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Stanford University Neurofiber Study
NCT07914387Phase 1Not yet recruiting
- Sponsor
- Stanford University
- Start
- Dec 2026
- Primary completion
- Jul 2027
- Countries
- 1
01
Overview
Phase 1, open-label trial in Parkinson's disease (PD) (2 arms), sponsored by Stanford University. Primary endpoints: Fecal Inflammatory Protein Quantification at 4 months and Bristol Stool Form Scale. Planned start Dec 2026; status: not yet recruiting.
02
Conditions
Parkinson's disease (PD)
Beyond the preview
Go deeper on NCT07914387.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07914387.